: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription

Articles published in PLoS One
Retrieve available abstracts of 388 articles:
HTML format

Single Articles

January 2025

WANG D, Chen S, Cui G, Wang D, et al
The survey of vaccination hesitancy among the residents in Jinan.
PLoS One. 2025;20:e0309431.
PubMed Abstract available

ABDEL-QADER DH, Abdel-Qader H, Silverthorne J, Kongkaew C, et al
Investigating the point prevalence, types, severity, causes and predictors of vaccines administration errors during COVID-19 pandemic in Jordan.
PLoS One. 2025;20:e0312050.
PubMed Abstract available

METELMANN S, Thompson A, Donten A, Oke S, et al
A systematic review to identify research gaps in studies modeling MenB vaccinations against Neisseria infections.
PLoS One. 2025;20:e0316184.
PubMed Abstract available

IGOMU EE, Mamman PH, Adamu J, Muhammad M, et al
Immunoinformatics design of a novel multiepitope vaccine candidate against non-typhoidal salmonellosis caused by Salmonella Kentucky using outer membrane proteins A, C, and F.
PLoS One. 2025;20:e0306200.
PubMed Abstract available

BANTIE GM, Tadege M, Nigussie TZ, Woya AA, et al
Regional disparities of full pentavalent vaccine uptake and the determinants in Ethiopia: Mapping and spatial analysis using the EDHS data.
PLoS One. 2025;20:e0312514.
PubMed Abstract available

EVEREST L, Henderson J, Ma C, Prebeg M, et al
Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort study.
PLoS One. 2025;20:e0313157.
PubMed Abstract available

TAKAHASHI Y, Sasamori Y, Higuchi R, Kaku A, et al
Effects of different educational interventions on cervical cancer knowledge and human papillomavirus vaccination uptake among young women in Japan: Preliminary results of a cluster randomized controlled trial.
PLoS One. 2025;20:e0311588.
PubMed Abstract available

HERGOTT M, Andreski M, Rovers J
Vaccine hesitancy among health paraprofessionals: A mixed methods study.
PLoS One. 2025;20:e0312708.
PubMed Abstract available

PHILLIPS G, Racine E, Naughton AM, Lane J, et al
Understanding uptake of the COVID-19 vaccination among the homeless: A mixed methods evaluation.
PLoS One. 2025;20:e0312617.
PubMed Abstract available

RAMAKRISHNAN U, Aggarwal T, Kondabagil K
Sequence and biochemical analysis of vaccinia virus A32 protein: Implications for in vitro stability and coiled-coil motif mediated regulation of the DNA-dependent ATPase activity.
PLoS One. 2025;20:e0316818.
PubMed Abstract available

RAHMAN MM, Masum MHU, Parvin R, Das SC, et al
Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
PLoS One. 2025;20:e0313559.
PubMed Abstract available

MOHAMMAD KM, Akhi AA, Kamrujjaman M
Bifurcation analysis of an influenza A (H1N1) model with treatment and vaccination.
PLoS One. 2025;20:e0315280.
PubMed Abstract available

NAHIAN M, Shahab M, Khan MR, Akash S, et al
Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae.
PLoS One. 2025;20:e0317216.
PubMed Abstract available

BRUGNOLI E, Delmastro M
Dynamics and triggers of misinformation on vaccines.
PLoS One. 2025;20:e0316258.
PubMed Abstract available

YU F, Younas Khan M, Bilal Riaz M, Ullah S, et al
Assessing the global dynamics of Nipah infection under vaccination and treatment: A novel computational modeling approach.
PLoS One. 2025;20:e0309360.
PubMed Abstract available

AGUILAR-PALMA SK, McCoy TP, Mann-Jackson L, Alonzo J, et al
Characteristics influencing COVID-19 testing and vaccination among Spanish-speaking Latine persons in North Carolina.
PLoS One. 2025;20:e0317794.
PubMed Abstract available

ARGHAL R, Rubin H, Saeedi Bidokhti S, Sarkar S, et al
Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.
PLoS One. 2025;20:e0316294.
PubMed Abstract available

DRUSZCZYNSKA M, Seweryn M, Wawrocki S, Pankowska A, et al
Interferon (IFN)-gamma (gamma) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population.
PLoS One. 2025;20:e0314400.
PubMed Abstract available

RAZAI MS, Ussher M, Goldsmith L, Hargreaves S, et al
Navigating vaccination in pregnancy: Qualitative study in 21 ethnically diverse pregnant women.
PLoS One. 2025;20:e0310823.
PubMed Abstract available

MUTHIRU AW, Muema J, Mutono N, Thumbi SM, et al
Beyond the jab: Unravelling the complexities of vaccine adoption for East Coast Fever in rural Kenya.
PLoS One. 2025;20:e0315906.
PubMed Abstract available

MULUGETA KT, Dawed MY, Teklu SW
Impact of media coverage on the transmission dynamics of TB with vaccines and treatment.
PLoS One. 2025;20:e0314324.
PubMed Abstract available

HEGAZI MA, Sayed MH, Butt NS, Alahmadi TS, et al
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis.
PLoS One. 2025;20:e0317983.
PubMed Abstract available

SOLANKI G, Cleary S, Little F
Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population.
PLoS One. 2025;20:e0317686.
PubMed Abstract available

HAMISI MA, Asri NAM, Yassim ASM, Suppian R, et al
A systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials.
PLoS One. 2025;20:e0317233.
PubMed Abstract available

SIDDIKI AZ, Alam S, Fuad Bin Hossen F, Alim MA, et al
Development of a multi-epitope chimeric vaccine in silico against Babesia bovis, Theileria annulata, and Anaplasma marginale using computational biology tools and reverse vaccinology approach.
PLoS One. 2025;20:e0312262.
PubMed Abstract available

ZUBAIR S, Parvaiz F, Abualait T, Al-Regaiey K, et al
Computational design of multi-epitope vaccine against Hepatitis C Virus infection using immunoinformatics techniques.
PLoS One. 2025;20:e0317520.
PubMed Abstract available

NAHIAN M, Khan MR, Rahman F, Reza HM, et al
Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori.
PLoS One. 2025;20:e0318750.
PubMed Abstract available

NAZ H, Timotheous R, Sarwar MF, Nadeem T, et al
Utilizing the subtractive proteomics approach to design ensemble vaccine against Candida lusitaniae for immune response stimulation; a bioinformatics study.
PLoS One. 2025;20:e0316264.
PubMed Abstract available

OTENG AGYEMAN F, Ma Z, Li M, Kwasi Sampene A, et al
Correction: Relevance of COVID-19 vaccine on the tourism industry: Evidence from China.
PLoS One. 2025;20:e0319203.
PubMed Abstract available

GANESHAN H, Huang J, Belmonte M, Belmonte A, et al
Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
PLoS One. 2025;20:e0318098.
PubMed Abstract available

GELYI EK, Azaare J, Bonso NK, Kpordoxah MR, et al
Impact of perceived factors of coronavirus infection on COVID-19 vaccine uptake among healthcare workers in Ghana-Evidence from a cross-sectional analysis.
PLoS One. 2025;20:e0318662.
PubMed Abstract available

KOSTINOV M, Chuchalin A, Chebykina A, Khrapunova I, et al
Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza.
PLoS One. 2025;20:e0313539.
PubMed Abstract available

PARVIN R, Masum MHU, Heema HP, Akter A, et al
Designing of a multiepitope-based vaccine against echinococcosis utilizing the potent Ag5 antigen: Immunoinformatics and simulation approaches.
PLoS One. 2025;20:e0310510.
PubMed Abstract available

SCHMIDHUBER S, Dickie J, Cserepes M, Tovari J, et al
WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses.
PLoS One. 2025;20:e0318293.
PubMed Abstract available

CONTRERAS M, Rafael M, Sobrino I, Almazan C, et al
Modelling protein-protein interactions for the design of vaccine chimeric antigens with protective epitopes.
PLoS One. 2025;20:e0318439.
PubMed Abstract available

TROGDON JG, Khanderia A, Brignole K, Lewis JA, et al
Gains vs losses in pay-for-performance: Stated preference evidence from a U.S. survey.
PLoS One. 2025;20:e0318704.
PubMed Abstract available

MAMELI C, Valsecchi C, Cereda D, Scarioni S, et al
Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy.
PLoS One. 2025;20:e0316340.
PubMed Abstract available

SODHI S, Chamali R, Praveen D, Sharma M, et al
Does integration matter? an international cross-sectional study on the relationship between perceived public health and primary care integration and COVID-19 vaccination rates.
PLoS One. 2025;20:e0317970.
PubMed Abstract available

SHI H, Zhang X, Ross TM
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection.
PLoS One. 2025;20:e0308680.
PubMed Abstract available

Correction: Determinants of the COVID-19 vaccine hesitancy spectrum.
PLoS One. 2025;20:e0315702.
PubMed Abstract available

MISHRA SK, Senathilake KS, Kumar N, Patel CN, et al
Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
PLoS One. 2025;20:e0318523.
PubMed Abstract available

MOTAMEDI H, Shoja S, Abbasi M
Immunoinformatic evaluation for the development of a potent multi-epitope vaccine against bacterial vaginosis caused by Gardnerella vaginalis.
PLoS One. 2025;20:e0316699.
PubMed Abstract available

MACHADO-VIEIRA R, Krause TM, Jones G, Teixeira AL, et al
Protective effects of psychiatric medications against COVID-19 mortality before vaccines.
PLoS One. 2025;20:e0310438.
PubMed Abstract available

KHATOONI Z, Broderick G, Anand SK, Wilson HL, et al
Combined immunoinformatic approaches with computational biochemistry for development of subunit-based vaccine against Lawsonia intracellularis.
PLoS One. 2025;20:e0314254.
PubMed Abstract available

OKITA G, Suenaga K, Sakaguchi M, Murakami T, et al
A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells.
PLoS One. 2025;20:e0312205.
PubMed Abstract available

ADAMU H, Lawal S, Bawa IA, Sani AM, et al
Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.
PLoS One. 2025;20:e0277585.
PubMed Abstract available

HTET H, Wichaidit W, Chuaychai A, Sottiyotin T, et al
Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study.
PLoS One. 2025;20:e0317714.
PubMed Abstract available

ASIIMWE S, Bagenda FN, Mugisa T
Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
PLoS One. 2025;20:e0306960.
PubMed Abstract available

BEIG M, Sholeh M, Moradkasani S, Shahbazi B, et al
Development of a multi-epitope vaccine against Acinetobacter baumannii: A comprehensive approach to combating antimicrobial resistance.
PLoS One. 2025;20:e0319191.
PubMed Abstract available

SHEN J, Ji C, Luo X, Hu Y, et al
Correction: Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.
PLoS One. 2025;20:e0320386.
PubMed Abstract available

ZUBAIR A, Al-Emam A, Ali M, Hussain SM, et al
Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the Asia.
PLoS One. 2025;20:e0317382.
PubMed Abstract available

SAHA S, Millier M, Samaranayaka A, Edmonds L, et al
Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol.
PLoS One. 2025;20:e0318893.
PubMed Abstract available

BAAKLINY M, Ghosn N, Saleh N, Maison P, et al
Effectiveness of the Pfizer-BioNTech (BNT162b2) vaccine against the omicron variant of SARS-CoV-2 among adults aged 50 and above: A case-control study in Lebanon, June 2022.
PLoS One. 2025;20:e0318344.
PubMed Abstract available

ALAHMADI S, Hoyle R, Head M, Brede M, et al
Modelling the mitigation of anti-vaccine opinion propagation to suppress epidemic spread: A computational approach.
PLoS One. 2025;20:e0318544.
PubMed Abstract available

ANTEHUNEGN TESEMA G, Sarfo M, Okeke SR, Ameyaw EK, et al
Unveiling the Drivers of Polio Vaccine Uptake: Insights from a Multi-Country Study of 37 Nations in Sub-Saharan Africa.
PLoS One. 2025;20:e0316884.
PubMed Abstract available

TAYLOR-ABDULAI HB, Dzantor EK, Mensah NK, Asumah MN, et al
Coronavirus disease 2019 (COVID-19) vaccine acceptability in Ghana: An urban-based population study.
PLoS One. 2025;20:e0319798.
PubMed Abstract available

LARA-RAMIREZ D, Santacruz-Tinoco CE, Ramon-Gallegos E, Munoz-Medina JE, et al
In silico design of Ebola virus Glycoprotein antigenic peptides as vaccine candidates.
PLoS One. 2025;20:e0319496.
PubMed Abstract available

OKAFUJI I, Washio R, Okafuji T, Tanaka Y, et al
Use of a cooling pack to reduce subcutaneous vaccine injection pain in children aged 3-6 years: A single-blind, randomized, parallel-group multicenter study.
PLoS One. 2025;20:e0318322.
PubMed Abstract available

SADONES O, Kramarska E, Sainz-Mejias M, Berisio R, et al
Identification of cross-reactive vaccine antigen candidates in Gram-positive ESKAPE pathogens through subtractive proteome analysis using opsonic sera.
PLoS One. 2025;20:e0319933.
PubMed Abstract available

LAMICHHANE R, Pathak ID, Pathak BD, Adhikari P, et al
Low Hepatitis B vaccination rates among medical students in South Asia: A systematic review and meta-analysis.
PLoS One. 2025;20:e0320330.
PubMed Abstract available

BURKE-GARCIA A, Cutroneo E, Afanaseva D, Madden K, et al
Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages.
PLoS One. 2025;20:e0319160.
PubMed Abstract available

Retraction: An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
PLoS One. 2025;20:e0322316.
PubMed

MALIK TM, Bakker KM, Oidtman RJ, Sharomi O, et al
A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States.
PLoS One. 2025;20:e0305892.
PubMed Abstract available

CARMOLA LR, Roebling AD, Khosravi D, Langsjoen RM, et al
Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA.
PLoS One. 2025;20:e0317972.
PubMed Abstract available

VO LT, Phan DQ, Tran HG, Nguyen LTP, et al
Hepatitis B vaccine coverage in health care students: a cross-sectional study in Vietnam.
PLoS One. 2025;20:e0320860.
PubMed Abstract available

DE BRITO KC, da Silva MFCR, Cardoso CW, Silva LK, et al
A randomized, controlled trial of a web-based tailored intervention to increase human papillomavirus vaccination among people living with HIV/AIDS.
PLoS One. 2025;20:e0319646.
PubMed Abstract available

XIE M, Younas Khan M, Ullah S, Farooq M, et al
Optimal control analysis for the transmission of Nipah infection with imperfect vaccination.
PLoS One. 2025;20:e0317408.
PubMed Abstract available

OROTTA M, Munseri P, Massawe RV, Orotta GM, et al
Hepatitis B virus: Prevalence, vaccination coverage and immune responses to immunization among healthcare workers at Muhimbili National Hospital.
PLoS One. 2025;20:e0321623.
PubMed Abstract available

VILLOTA SD, Veloz-Villavicencio E, Garcia-Iturralde S, Arevalo JV, et al
Validation of new equipment for SARS-CoV-2 diagnosis in Ecuador: Detection of the virus and antibodies generated by disease and vaccines with one POC device.
PLoS One. 2025;20:e0321794.
PubMed Abstract available

IWU CD, Shrestha P, Littman AJ, Hood JE, et al
The association between healthcare access and shingles vaccination among older adults in Virginia, United States.
PLoS One. 2025;20:e0316429.
PubMed Abstract available

MURPHY R, Pomerantz L, Kuruppumullage Don P, Sung Kim J, et al
Correction: Age and political leaning predict COVID-19 vaccination status at a large, multi-campus, public university in Pennsylvania: A cross-sectional survey.
PLoS One. 2025;20:e0322942.
PubMed Abstract available

Retraction: Immunoinformatic strategy for developing multi-epitope subunit vaccine against Helicobacter pylori.
PLoS One. 2025;20:e0323864.
PubMed

Retraction: Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.
PLoS One. 2025;20:e0323771.
PubMed

HIRANBURANA N, Thippamom N, Avihingsanon A, Wacharapluesadee S, et al
Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination.
PLoS One. 2025;20:e0317940.
PubMed Abstract available

YU H, Bonett S, Oyiborhoro U, Aryal S, et al
Correction: Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
PLoS One. 2025;20:e0323661.
PubMed Abstract available

RAPAJIC-MORAN I, Filipic B, Rajkovic D, Rakic M, et al
Strengthening the role of community pharmacy in HPV vaccination roll-out in Serbia at national and local levels: A pharmacy-based education approach.
PLoS One. 2025;20:e0322584.
PubMed Abstract available

VANOUDENHOVE J, Liu Y, Nelakanti R, Kim D, et al
Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant.
PLoS One. 2025;20:e0320744.
PubMed Abstract available

EZEZIKA O, Pellitier Z, Muhimpundu S, Daboud C, et al
Exploring vaccination attitudes in African communities in Canada: A mixed-methods study protocol.
PLoS One. 2025;20:e0319584.
PubMed Abstract available

MATHKOUR A, Alzahrani AH, Narapureddy BR, Alqahtani FM, et al
Prevalence and risk factors of burnout among employees at COVID-19 vaccination centers: A cross-sectional study.
PLoS One. 2025;20:e0322803.
PubMed Abstract available

Retraction: In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques.
PLoS One. 2025;20:e0324093.
PubMed

DE LA CRUZ HERRERA M, Fuster-Casanovas A, Miro Catalina Q, Cigarrran Mensa M, et al
Use of virtual reality in the reduction of pain after the administration of vaccines among children in primary care centers in Central Catalonia: Randomized clinical trial.
PLoS One. 2025;20:e0322840.
PubMed Abstract available

METKIE KA, Asgedom YS, Sertsewold SG, Abebe M, et al
Polio vaccination and marginal effects among children aged 12-23 months in Lesotho using 2024 LDHS data: A multilevel analysis approach.
PLoS One. 2025;20:e0322731.
PubMed Abstract available

LAYTON JB, Lloyd PC, Peetluk LS, Jiao Y, et al
Effectiveness over time of a primary series of the original monovalent COVID-19 vaccines in adults in the United States.
PLoS One. 2025;20:e0320434.
PubMed Abstract available

Retraction: Exploratory algorithms to devise multi-epitope subunit vaccine by examining HIV-1 envelope glycoprotein: An immunoinformatics and viroinformatics approach.
PLoS One. 2025;20:e0324076.
PubMed

Retraction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
PLoS One. 2025;20:e0324071.
PubMed

SIM J, Smith LE, Amlot R, Rubin GJ, et al
Discrimination of a single-item scale to measure intention to have a COVID-19 vaccine.
PLoS One. 2025;20:e0322503.
PubMed Abstract available

MANTINA NM, Smith J, Miiro FN, Magrath PA, et al
Perspectives of HPV vaccine decision-making among young adults: A qualitative systematic review and evidence synthesis.
PLoS One. 2025;20:e0321448.
PubMed Abstract available

LI Y, Zhao IY, Lu W, Leung SF, et al
Are people willing to take regular vaccinations? A qualitative study among diverse ethnic groups in Hong Kong.
PLoS One. 2025;20:e0318631.
PubMed Abstract available

KIM SH, Jung M
Disentangling behavioral determinants of seasonal influenza vaccination in post-corona era: An integrated model approach.
PLoS One. 2025;20:e0323184.
PubMed Abstract available

NASIR M, Weeks WB, Gholami S, Marfin A, et al
Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning.
PLoS One. 2025;20:e0323384.
PubMed Abstract available

SHIN E, Yun JS, Lee YR, Cha HR, et al
Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
PLoS One. 2025;20:e0322147.
PubMed Abstract available

XIA Z, Meng J, Wang X, Liu P, et al
Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: A meta-analysis of randomized controlled trials.
PLoS One. 2025;20:e0321511.
PubMed Abstract available

LANG HP, Almeer FF, Jenkins MK, Friedenberg SG, et al
Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs.
PLoS One. 2025;20:e0323823.
PubMed Abstract available

OYEDEJI O, North C, Kintziger KW, Ehrlich S, et al
Understanding young adults' perceptions regarding human papillomavirus vaccination: A qualitative study.
PLoS One. 2025;20:e0323063.
PubMed Abstract available

ELKARHAT Z, Tifrouin I, Bamouh Z, Tadlaoui KO, et al
First identification of ORF virus causing contagious ecthyma in Morocco (MOR20): Genomic, phylogenetic, and sequence variants analyses for vaccine design.
PLoS One. 2025;20:e0323383.
PubMed Abstract available

BELICHENKO PV, Madani R, Rey-Bellet L, Pihlgren M, et al
Correction: An Anti-beta-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome.
PLoS One. 2025;20:e0324280.
PubMed Abstract available

SOARES P, Gomez V, Gaio V, Santos JA, et al
A protocol for high-dose quadrivalent influenza vaccine effectiveness in the community and long-term care facilities using electronic health records.
PLoS One. 2025;20:e0314177.
PubMed Abstract available

NOREEN K, Khalid SN, Javaid M, Khan SA, et al
Public Health Implications of Introducing Human Papillomavirus (HPV) Vaccination in Pakistan: A protocol for a mixed-method study to explore community perceptions and health system preparedness.
PLoS One. 2025;20:e0323826.
PubMed Abstract available

AJIT J, Chen Q, Ung T, Rosenberger M, et al
beta-glucan induced trained immunity enhances antibody levels in a vaccination model in mice.
PLoS One. 2025;20:e0323376.
PubMed Abstract available

YAN X, Liu Y, Chen F, Chang Z, et al
The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot, and mouth disease: A systematic review and meta-analysis.
PLoS One. 2025;20:e0323782.
PubMed Abstract available

OVER D, Santana E, Amaral EFL, Lakkimsetti C, et al
A comprehensive analysis of COVID-19 vaccination behavior: The influence of religion, information sources, political leanings, and demographic factors.
PLoS One. 2025;20:e0323815.
PubMed Abstract available

WARD CL, Rojas Castro MY, Chakhunashvili G, Chitadze N, et al
COVID-19 vaccine effectiveness among healthcare workers during the Omicron period in the country of Georgia, January - June 2022.
PLoS One. 2025;20:e0311337.
PubMed Abstract available

WU H, He X, Cao Y, Gao W, et al
Adverse events affecting recovery from seasonal influenza vaccination in the hypertensive population: A population-based pharmacovigilance analysis.
PLoS One. 2025;20:e0310474.
PubMed Abstract available

SAMARA KA, Barqawi HJ, Alhayali DM, Kannas SM, et al
Evaluation of knowledge, attitudes and vaccine hesitancy towards MMR vaccine among parents in the United Arab Emirates.
PLoS One. 2025;20:e0324629.
PubMed Abstract available

JONGKEES MJ, Bogers S, de Vries RD, GeurtsvanKessel CH, et al
Longitudinal assessment of COVID-19 vaccine immunogenicity in people with HIV stratified by CD4+ T-cell count in the Netherlands: A two-year follow-up study.
PLoS One. 2025;20:e0323792.
PubMed Abstract available

PUCA C, Wood-Kenney P, Nelson N, Hansen J, et al
"Our kids are our future": Barriers and facilitators to vaccine uptake and timeliness among Aboriginal children younger than five years in Boorloo (Perth), Western Australia.
PLoS One. 2025;20:e0317946.
PubMed Abstract available

PARIDANS M, Dardenne N, Gillain N, Husson E, et al
Removing barriers to COVID-19 vaccine intention in a university population: Results of a serial mediation study through the dimensions of the Health Belief Model.
PLoS One. 2025;20:e0322881.
PubMed Abstract available

DORJEE K, Sadoff RC, Mansour FR, Dorjee S, et al
Menstrual disturbance associated with COVID-19 vaccines: A comprehensive systematic review and meta-analysis.
PLoS One. 2025;20:e0320162.
PubMed Abstract available

HAU SJ, Fittipaldi N, Payen S, Grenier D, et al
Protection induced in pigs previously infected by the non-virulent strain 1330 of Streptococcus suis serotype 2 is not due to the secretion of the bacteriocin suicin.
PLoS One. 2025;20:e0323370.
PubMed Abstract available

BHAT KD, Bhattacharya H, Jayaraman Y, Kanungo S, et al
Hepatitis B virus infection among children aged 1- 5 years of Mayurbhanj district (Odisha), India: A prospective study protocol.
PLoS One. 2025;20:e0317621.
PubMed Abstract available

SONG MC, Ha J, Park S, Kang H, et al
Mortality in severe serious adverse events following heterologous and homologous prime-boost vaccination strategies for SARS-CoV-2: A retrospective cohort study.
PLoS One. 2025;20:e0323736.
PubMed Abstract available

NATALIA YA, Molenberghs G, Neyens T, Hens N, et al
Empirical analysis of COVID-19 confirmed cases, hospitalizations, vaccination, and international travel across Belgian provinces in 2021.
PLoS One. 2025;20:e0322017.
PubMed Abstract available

PODDA M, Savojardo C, Luigi Martelli P, Casadio R, et al
A descriptor-free machine learning framework to improve antigen discovery for bacterial pathogens.
PLoS One. 2025;20:e0323895.
PubMed Abstract available

HARTVIGSEN G, Dimitroff Y
Modeling the SARS-CoV-2 epidemic and the efficacy of different vaccines across different network structures.
PLoS One. 2025;20:e0325129.
PubMed Abstract available

CARAZO S, Skowronski DM, Brousseau N, Guay CA, et al
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up.
PLoS One. 2025;20:e0325269.
PubMed Abstract available

FATIREGUN AA, Nic Lochlainn L, Kabore L, Dosumu M, et al
Correction: Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
PLoS One. 2025;20:e0325918.
PubMed Abstract available

January 2024

ABER JO, Bongomin F, Opio SL, Ochola E, et al
Hepatitis B vaccine uptake and associated factors among adults of Gulu city in Northern Uganda: A community-based cross-sectional study.
PLoS One. 2024;19:e0297617.
PubMed Abstract available

HOU Y, Bidkhori H
Multi-feature SEIR model for epidemic analysis and vaccine prioritization.
PLoS One. 2024;19:e0298932.
PubMed Abstract available

Retraction: Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus.
PLoS One. 2024;19:e0300096.
PubMed

KONLAN MY, Mahama F, Abubakari BB, Konka P, et al
Predictors of vaccination card retention in Tamale Metropolis, Ghana.
PLoS One. 2024;19:e0292765.
PubMed Abstract available

DIAS E, Diniz AMA, Souto GR, Guerra HL, et al
Predicting COVID-19 cases in Belo Horizonte-Brazil taking into account mobility and vaccination issues.
PLoS One. 2024;19:e0269515.
PubMed Abstract available

BASHIR IM, Al-Waleedi AA, Al-Shaibani SM, Rajamanar M, et al
Strengthening laboratories in response to outbreaks in humanitarian emergencies and conflict settings: Results, challenges and lessons from expanding PCR diagnostic capacities for COVID-19 testing in Yemen.
PLoS One. 2024;19:e0298603.
PubMed Abstract available

WU S, Li Y, Baral S, Mishra S, et al
Protection of prior SARS-CoV-2 infection, COVID-19 boosters, and hybrid immunity against Omicron severe illness: A population-based cohort study of five million residents in Canada.
PLoS One. 2024;19:e0299304.
PubMed Abstract available

SENJAM SS, Manna S, Goel G, Balhara YPS, et al
Vaccination coverage against COVID-19 among rural population in Haryana, India: A cross-sectional study.
PLoS One. 2024;19:e0299564.
PubMed Abstract available

TANNER AE, Hall MA, Aguilar-Palma SK, Mann-Jackson L, et al
Understanding uptake of COVID-19 testing, vaccination, and boosters among Spanish-speaking Latines in the United States: Qualitative insights from Spanish speakers and key informants.
PLoS One. 2024;19:e0296812.
PubMed Abstract available

GIANNOUCHOS TV, Hair NL, Olatosi B, Li X, et al
Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.
PLoS One. 2024;19:e0300198.
PubMed Abstract available

ZHANG X, Han X, Chen B, Fu X, et al
Influence of nutritional supplements on antibody levels in pregnant women vaccinated with inactivated SARS-CoV-2 vaccines.
PLoS One. 2024;19:e0289255.
PubMed Abstract available

AGIMAS MC, Alemayehu MA, Derseh NM, Aragaw FM, et al
Correction: Spatial pattern and associated factors of timely vaccination in Ethiopia using EDHS-2016 data: A multilevel and spatial analysis.
PLoS One. 2024;19:e0300482.
PubMed Abstract available

MALITA MA, Manolescu LSC, Perieanu VS, Babiuc I, et al
COVID-19 and flu vaccination in Romania, post pandemic lessons in healthcare workers and general population.
PLoS One. 2024;19:e0299568.
PubMed Abstract available

WILLIAMS SV, Akande T, Abbas K
Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.
PLoS One. 2024;19:e0297326.
PubMed Abstract available

KECHAGIAS KS, Laleye JD, Drmota J, Geropoulos G, et al
Minimal change disease following COVID-19 vaccination: A systematic review.
PLoS One. 2024;19:e0297568.
PubMed Abstract available

SCHRIJVERS-GONLAG M, Skarpe C, Julkunen-Tiitto R, Poleo ABS, et al
Phenolic concentrations and carbon/nitrogen ratio in annual shoots of bilberry (Vaccinium myrtillus) after simulated herbivory.
PLoS One. 2024;19:e0298229.
PubMed Abstract available

ARUMAE K, Realo A, Ausmees L, Allik J, et al
Self- and informant-reported personality traits and vaccination against COVID-19.
PLoS One. 2024;19:e0287413.
PubMed Abstract available

SUWANBAMRUNG C, Srinam B, Promkool P, Suwannakarn W, et al
Uptake of COVID-19 vaccine among high-risk urban populations in Southern Thailand using the COM-B model.
PLoS One. 2024;19:e0300509.
PubMed Abstract available

PANG Y, Robbs C, Wang J
A longitudinal study of the COVID-19 pandemic impact on mental health in ophthalmic personnel and students.
PLoS One. 2024;19:e0300144.
PubMed Abstract available

TOWNSLEY H, Gahir J, Russell TW, Greenwood D, et al
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
PLoS One. 2024;19:e0294897.
PubMed Abstract available

LEE DH, Lee SH, Kim AR, Quan FS, et al
Correction: Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
PLoS One. 2024;19:e0301214.
PubMed Abstract available

LI Y, Li J, He J, Tao C, et al
AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
PLoS One. 2024;19:e0300919.
PubMed Abstract available

LANZA-LEON P, Cantarero-Prieto D, Pascual-Saez M
Exploring trends and determinants of basic childhood vaccination coverage: Empirical evidence over 41 years.
PLoS One. 2024;19:e0300404.
PubMed Abstract available

GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
Web-based survey investigating cardiovascular complications in hypermobile Ehlers-Danlos syndrome after COVID-19 infection and vaccination.
PLoS One. 2024;19:e0298272.
PubMed Abstract available

ZHENG D, Sun Q, Su Z, Kong F, et al
Correction: Enhancing Specific-Antibody Production to the ragB Vaccine with GITRL That Expand Tfh, IFN-gamma+ T Cells and Attenuates Porphyromonas gingivalis Infection in Mice.
PLoS One. 2024;19:e0301151.
PubMed Abstract available

KOSKAN A, Larkey L, Todd M, Kim SW, et al
Protocol for a community-based digital storytelling pilot intervention to reduce Hispanic parents' vaccine hesitancy to immunize their children against COVID-19.
PLoS One. 2024;19:e0299787.
PubMed Abstract available

TRZEBINSKI W, Trzebinski J
How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
PLoS One. 2024;19:e0300814.
PubMed Abstract available

UMER BA, Noyce RS, Kieser Q, Favis NA, et al
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.
PLoS One. 2024;19:e0298437.
PubMed Abstract available

STOSIC M, Plavsa D, Jovanovic V, Veljkovic M, et al
Factors associated with COVID-19 among hospitalized patients with severe acute respiratory infections in Serbia, 2022-2023: A test negative case-control study.
PLoS One. 2024;19:e0299210.
PubMed Abstract available

WALSH-BUHI ML, Houghton RF, Valdez D, Walsh-Buhi ER, et al
A theory-based assessment of mpox: Findings from a nationally representative survey of U.S. adults.
PLoS One. 2024;19:e0299599.
PubMed Abstract available

LEE KS, Go MJ, Choi YY, Kim MK, et al
Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service.
PLoS One. 2024;19:e0300306.
PubMed Abstract available

AZAMAR-LLAMAS D, Arenas-Martinez JS, Olivas-Martinez A, Jimenez JV, et al
Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico.
PLoS One. 2024;19:e0301198.
PubMed Abstract available

BRAY LA, Jervis LL, Janitz AE, Ross L, et al
Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships.
PLoS One. 2024;19:e0300872.
PubMed Abstract available

DIMNJAKOVIC J, Buble T, Ivanko P, Poljicanin T, et al
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
PLoS One. 2024;19:e0301056.
PubMed Abstract available

PAUDEL S, Apostolakos I, Vougat Ngom R, Tilli G, et al
A systematic review and meta-analysis on the efficacy of vaccination against colibacillosis in broiler production.
PLoS One. 2024;19:e0301029.
PubMed Abstract available

THERESA POOL SN, Shroff EH, Chetty A, Lewis L, et al
Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.
PLoS One. 2024;19:e0299747.
PubMed Abstract available

AGIMAS MC, Belew AK, Sisay M, Daniel Baffa L, et al
Spatial variations and determinants of timely completion of vaccination in Ethiopia using further analysis of EDHS 2019 data: Spatial and multilevel analysis.
PLoS One. 2024;19:e0301409.
PubMed Abstract available

FISMAN DN, Amoako A, Simmons A, Tuite AR, et al
Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.
PLoS One. 2024;19:e0297093.
PubMed Abstract available

SILVA LA, Souza MF, Carvalho TP, Santana CH, et al
Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as vaccine adjuvants in mice.
PLoS One. 2024;19:e0298117.
PubMed Abstract available

HERNANDEZ-BELLO J, Lorenzo-Leal AC, Munoz-Valle JF, Morales-Nunez JJ, et al
Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following vaccination with Ad5-nCoV (CanSino) in the Mexican population.
PLoS One. 2024;19:e0299520.
PubMed Abstract available

MWANGI LW, Omuse G, Adam R, Ong'ete G, et al
Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and non-clinical healthcare workers at a tertiary facility in Kenya.
PLoS One. 2024;19:e0299302.
PubMed Abstract available

ECHEVERRI TRIBIN F, Williams E, Testamarck V, Carreno JM, et al
Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort.
PLoS One. 2024;19:e0292566.
PubMed Abstract available

RICCI CONESA H, Skroder H, Norton N, Bencina G, et al
Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.
PLoS One. 2024;19:e0297098.
PubMed Abstract available

THANGARAJ JWV, Prosperi C, Kumar MS, Hasan AZ, et al
Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
PLoS One. 2024;19:e0297385.
PubMed Abstract available

ALAMARES-SAPUAY J, Kishko M, Lai C, Parrington M, et al
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate DeltaNS2/Delta1313/I1314L increase the stability of infectivity and content of prefusion F protein.
PLoS One. 2024;19:e0301773.
PubMed Abstract available

UNFRIED K, Priebe J
Who shares fake news on social media? Evidence from vaccines and infertility claims in sub-Saharan Africa.
PLoS One. 2024;19:e0301818.
PubMed Abstract available

RAZAI MS, Mansour R, Ravindran P, Freeman S, et al
Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review.
PLoS One. 2024;19:e0298407.
PubMed Abstract available

HOSSAIN FB, Jayasinghe S, Blazek K, He WQ, et al
Pneumococcal vaccination and primary care presentations for acute respiratory tract infection and antibiotic prescribing in older adults.
PLoS One. 2024;19:e0299924.
PubMed Abstract available

ZHANG Q, Tiwari S, Wen J, Wang S, et al
Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
PLoS One. 2024;19:e0300524.
PubMed Abstract available

RENEER ZB, Bergeron HC, Reynolds S, Thornhill-Wadolowski E, et al
mRNA vaccines encoding influenza virus hemagglutinin (HA) elicits immunity in mice from influenza A virus challenge.
PLoS One. 2024;19:e0297833.
PubMed Abstract available

BADE V, Schmitz H, Tawiah BB
Regional variations in vaccination against COVID-19 in Germany.
PLoS One. 2024;19:e0296976.
PubMed Abstract available

SANVEE-BLEBO LM, Adewuyi PA, Whesseh FK, Babalola OJ, et al
COVID-19 vaccine hesitancy among adults in Liberia, April-May 2021.
PLoS One. 2024;19:e0297089.
PubMed Abstract available

ZAID SNA, Abdul Kadir A, Mohd Noor N, Ahmad B, et al
Translation and trans-cultural adaptation to the Malay version of the COVID-19 vaccine hesitancy questionnaire among healthcare workers in Malaysia.
PLoS One. 2024;19:e0302237.
PubMed Abstract available

LERDSAMRAN H, Anusorntanawat R, Sangsiriwut K, Sawadpongpan S, et al
Higher correlation between neutralizing antibodies and surrogate neutralizing or binding antibodies in COVID-19 patients than vaccine recipients.
PLoS One. 2024;19:e0298033.
PubMed Abstract available

TAN H, Liu J, Zhang Y
Effects of COVID-19 vaccine safety framing on parental reactions.
PLoS One. 2024;19:e0302233.
PubMed Abstract available

MARQUEZ-MARTINEZ S, Salisch N, Serroyen J, Zahn R, et al
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
PLoS One. 2024;19:e0299215.
PubMed Abstract available

THIELMANN A, Schmitz MT, Welchowski T, Weltermann B, et al
Effectiveness of the online-eLearning program KeepCoool at improving the vaccine cold chain in general practices.
PLoS One. 2024;19:e0301847.
PubMed Abstract available

KYAKUWA N, Kimbugwe G, Nakanjako F, Kalute H, et al
High uptake of COVID-19 vaccines among healthcare workers in urban Uganda.
PLoS One. 2024;19:e0277072.
PubMed Abstract available

LIN L, Demirhan H, P Johnstone-Robertson S, Lal R, et al
Assessing the impact of Australia's mass vaccination campaigns over the Delta and Omicron outbreaks.
PLoS One. 2024;19:e0299844.
PubMed Abstract available

SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
PLoS One. 2024;19:e0298771.
PubMed Abstract available

O'KENNEDY MM, Roth R, Ebersohn K, du Plessis LH, et al
Immunogenic profile of a plant-produced nonavalent African horse sickness viral protein 2 (VP2) vaccine in IFNAR-/- mice.
PLoS One. 2024;19:e0301340.
PubMed Abstract available

CHISTY ZA, Li DD, Haile M, Houston H, et al
Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
PLoS One. 2024;19:e0301367.
PubMed Abstract available

COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
PLoS One. 2024;19:e0290221.
PubMed Abstract available

FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
PLoS One. 2024;19:e0301830.
PubMed Abstract available

KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
PLoS One. 2024;19:e0301460.
PubMed Abstract available

KASSA ZY, Scarf V, Turkmani S, Fox D, et al
Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
PLoS One. 2024;19:e0301994.
PubMed Abstract available

RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
PLoS One. 2024;19:e0288894.
PubMed Abstract available

TAMARGO JA, Martin HR, Diaz-Martinez J, Delgado-Enciso I, et al
Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
PLoS One. 2024;19:e0297327.
PubMed Abstract available

YAMAJI T, Harada T, Hashimoto Y, Nakano Y, et al
Effects of BNT162b2 mRNA Covid-19 vaccine on vascular function.
PLoS One. 2024;19:e0302512.
PubMed Abstract available

HWANG LA, Vaithilingam S, Ng JWJ, Nair M, et al
The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia.
PLoS One. 2024;19:e0301383.
PubMed Abstract available

JANNAT Z, Das H, Ali MW, Wahed T, et al
Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
PLoS One. 2024;19:e0302056.
PubMed Abstract available

JOHN FA, Criollo V, Gaghan C, Armwood A, et al
Immunization of turkeys with Clostridium septicum alpha toxin-based recombinant subunit proteins can confer protection against experimental Clostridial dermatitis.
PLoS One. 2024;19:e0302555.
PubMed Abstract available

CHENG MC, Lai GH, Tsai YL, Lien YY, et al
Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
PLoS One. 2024;19:e0303371.
PubMed Abstract available

KUMAR A, Misra G, Mohandas S, Yadav PD, et al
Multi-epitope vaccine design using in silico analysis of glycoprotein and nucleocapsid of NIPAH virus.
PLoS One. 2024;19:e0300507.
PubMed Abstract available

RAMOS A, Martins S, Marinho AS, Norton P, et al
Evaluation of SARS-CoV-2 interferon gamma release assay in BNT162b2 vaccinated healthcare workers.
PLoS One. 2024;19:e0303244.
PubMed Abstract available

CHOI Y, Kim IK, Kim SJ, Kim HS, et al
Predictors of positive tuberculin skin test in neonates exposed to pulmonary tuberculosis.
PLoS One. 2024;19:e0303050.
PubMed Abstract available

RAJOROMANANA B, Nyirenda G, Edosoa GT, Andrianasolo RL, et al
Dog ecology and rabies control including canine vaccination coverage: Impacts from a survey in Madagascar.
PLoS One. 2024;19:e0302690.
PubMed Abstract available

BURUSIE A, Enquesilassie F, Salazar-Austin N, Addissie A, et al
Determinants of tuberculosis disease development in children in central Ethiopia: A matched case-control study.
PLoS One. 2024;19:e0300731.
PubMed Abstract available

NOUR D, Ismail MB, Osman M, Rafei R, et al
Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon.
PLoS One. 2024;19:e0302579.
PubMed Abstract available

AGGARWAL S, Singh L, Alam U, Sharma S, et al
COVID-19 vaccine hesitancy among adults in India: A primary study based on health behavior theories and 5C psychological antecedents model.
PLoS One. 2024;19:e0294480.
PubMed Abstract available

OMALE UI, Ikegwuonu CO, Nkwo GE, Nwali UIA, et al
COVID-19 and COVID-19 vaccination experiences and perceptions among health workers during the pandemic in Ebonyi state, Nigeria: An analytical cross-sectional study.
PLoS One. 2024;19:e0303172.
PubMed Abstract available

VAMEGHI M, Saatchi M, Bahrami G, Soleimani F, et al
How did we protect children against COVID-19 in Iran? Prevalence of COVID-19 and vaccination in the socio-economic context of COVID-19 epidemic.
PLoS One. 2024;19:e0303043.
PubMed Abstract available

IQBAL NT, Ahmed K, Sattar T, Aziz F, et al
BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.
PLoS One. 2024;19:e0302722.
PubMed Abstract available

Retraction: Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection.
PLoS One. 2024;19:e0303549.
PubMed

WHELAN AO, Flick-Smith HC, Walker NJ, Abraham A, et al
A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model.
PLoS One. 2024;19:e0294998.
PubMed Abstract available

KIM S, Lilani A, Redemptus C, Campana K, et al
A pre-post evaluation study of a social media-based COVID-19 communication campaign to improve attitudes and behaviors toward COVID-19 vaccination in Tanzania.
PLoS One. 2024;19:e0300206.
PubMed Abstract available

MOIN AT, Rani NA, Patil RB, Robin TB, et al
In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxviruses.
PLoS One. 2024;19:e0300778.
PubMed Abstract available

URAZAYEVA ST, Kurmangaliyeva SS, Kaliyev AA, Tussupkaliyeva KS, et al
Attitude toward vaccination against COVID-19 and acceptance of the national "QazVac" vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey.
PLoS One. 2024;19:e0303854.
PubMed Abstract available

KHEZRI M, McKnight C, Weng CA, Kimball S, et al
COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City.
PLoS One. 2024;19:e0303394.
PubMed Abstract available

WASSIE GT, Ambelie YA, Adebabay T, Yeshiwas AG, et al
Covid-19 vaccine uptake and its associated factors among adult population in Dangila district, Awi Zone, Northwest Ethiopia: A mixed method study.
PLoS One. 2024;19:e0302531.
PubMed Abstract available

YASEEN A, DeSantis SM, Sabharwal R, Talebi Y, et al
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
PLoS One. 2024;19:e0303420.
PubMed Abstract available

GICHUKI J, Ngoye B, Wafula F
"I'll take them another day": A qualitative study exploring the socio-behavioral complexities of childhood vaccination in urban poor settlements.
PLoS One. 2024;19:e0303215.
PubMed Abstract available

HURST JH, Shaik-Dasthagirisaheb YB, Truong L, Boiditswe SC, et al
Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019).
PLoS One. 2024;19:e0302400.
PubMed Abstract available

BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
PLoS One. 2024;19:e0301997.
PubMed Abstract available

COBB J, Rawson J, Gonzalez N, Orr C, et al
Reversal of diabetes by an oral Salmonella-based vaccine in acute and progressive diabetes in NOD mice.
PLoS One. 2024;19:e0303863.
PubMed Abstract available

KASZTELEWICZ B, Skrok K, Burzynska J, Migdal M, et al
Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.
PLoS One. 2024;19:e0301612.
PubMed Abstract available

TRZEBINSKI W, Trzebinski J
Correction: How does collectivism help deal with perceived vaccine artificiality? The case of COVID-19 vaccination intent in European young adults.
PLoS One. 2024;19:e0304372.
PubMed Abstract available

LOPEZ-CODONY V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli ME, et al
Assessing the reduction of viral infectivity in HPV16/18-positive women after one, two, and three doses of Gardasil-9 (RIFT): Study protocol.
PLoS One. 2024;19:e0304080.
PubMed Abstract available

YOSHIMURA M, Honda Y, Yonemitsu E, Kuraoka K, et al
Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
PLoS One. 2024;19:e0301688.
PubMed Abstract available

LIU Y, Zhang C, Wang Y, Luo X, et al
Seroepidemiology of pertussis in Huzhou: A population-based, cross-sectional study.
PLoS One. 2024;19:e0303508.
PubMed Abstract available

BRIZUELA M, Palermo MC, Alconada T, Sandoval MM, et al
Nasopharyngeal carriage of Streptococcus pneumoniae in Latin America and the Caribbean: A systematic review and meta-analysis.
PLoS One. 2024;19:e0297767.
PubMed Abstract available

TAMIR TT, Workneh BS, Mekonen EG, Zegeye AF, et al
Coverage, spatial distribution and determinants of childhood inactivated poliovirus vaccine immunization in Ethiopia.
PLoS One. 2024;19:e0301933.
PubMed Abstract available

HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
PLoS One. 2024;19:e0300152.
PubMed Abstract available

ARBEL Y, Arbel Y, Kerner A, Kerner M, et al
Can COVID-19 herd immunity be achieved at a city level?
PLoS One. 2024;19:e0299574.
PubMed Abstract available

MERAYA AM, Syed MH, Shabi AA, Madkhali HA, et al
Assessment of community pharmacists' knowledge, attitudes and their willingness to provide vaccination services in Saudi Arabia.
PLoS One. 2024;19:e0304287.
PubMed Abstract available

LE T, Flores M, Omaleki V, Hassani A, et al
Assessing the impact of institutional mistrust on parental endorsement for COVID-19 vaccination among school communities in San Diego County, California.
PLoS One. 2024;19:e0295618.
PubMed Abstract available

GARG N, Tellier G, Vale N, Kluge J, et al
Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
PLoS One. 2024;19:e0303450.
PubMed Abstract available

ARTEMCHUK O, Evlampidou I
Knowledge, attitudes and practices survey towards pneumococcal infection and vaccination among primary health care physicians, Ukraine, 2021.
PLoS One. 2024;19:e0304346.
PubMed Abstract available

SASSE K, Mahabir R, Gkountouna O, Crooks A, et al
Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media.
PLoS One. 2024;19:e0301488.
PubMed Abstract available

RIBEIRO LB, Gazzinelli A, Santiago HDC, Fiuza JA, et al
Public engagement for the conduct of a controlled human infection study testing vaccines against Necator americanus (hookworm) in areas of active hookworm transmission in Brazil.
PLoS One. 2024;19:e0299022.
PubMed Abstract available

CHEN LP, Singh-Verdeflor K, Kelly MM, Sklansky DJ, et al
Disparities in COVID-19 vaccine intentions, testing and trusted sources by household language for children with medical complexity.
PLoS One. 2024;19:e0305553.
PubMed Abstract available

CHICOINE N, Schnipper N, Griffin J
The role of hesitancy and infrastructure in the equity and efficiency of COVID-19 vaccine administration.
PLoS One. 2024;19:e0304416.
PubMed Abstract available

BREWER SE, Bertin KB, Suresh K, LoudHawk-Hedgepeth C, et al
Factors in COVID-19 vaccine uptake in five racial/ethnic Colorado communities: A report from the Colorado CEAL project.
PLoS One. 2024;19:e0305160.
PubMed Abstract available

CHEN F, Nakanishi H, Sekizawa Y, Ochi S, et al
Investigating the causal effects of COVID-19 vaccination on the adoption of protective behaviors in Japan: Insights from a fuzzy regression discontinuity design.
PLoS One. 2024;19:e0305043.
PubMed Abstract available

DALKY A, Quran TO, Abuhammad S, Al-Faraj HM, et al
COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
PLoS One. 2024;19:e0305314.
PubMed Abstract available

ASHCROFT R, Donnelly C, Sheffield P, Lam S, et al
A qualitative examination of the experiences and perspectives of interprofessional primary health care teams in the distribution of the COVID-19 vaccination in Ontario, Canada.
PLoS One. 2024;19:e0304616.
PubMed Abstract available

CHIEN LC, Marquez ER, Smith S, Tu T, et al
Exploring the role of the social vulnerability index in understanding COVID-19 immunization rates.
PLoS One. 2024;19:e0302934.
PubMed Abstract available

CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
PLoS One. 2024;19:e0303303.
PubMed Abstract available

GURAV YK, Bagepally BS, Chitpim N, Sobhonslidsuk A, et al
Cost-effective analysis of hepatitis A vaccination in Kerala state, India.
PLoS One. 2024;19:e0306293.
PubMed Abstract available

FARHAN M, Shah Z, Ling Z, Shah K, et al
Global dynamics and computational modeling for analyzing and controlling Hepatitis B: A novel epidemic approach.
PLoS One. 2024;19:e0304375.
PubMed Abstract available

BARDACH A, Ruvinsky S, Palermo MC, Alconada T, et al
Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis.
PLoS One. 2024;19:e0304978.
PubMed Abstract available

SAMMAN N, Mohabatkar H, Behbahani M, Ganjlikhani Hakemi M, et al
Bioinformatics design of a peptide vaccine containing sarcoma antigen NY-SAR-35 epitopes against breast cancer and evaluation of its immunological function in BALB/c mouse model.
PLoS One. 2024;19:e0306117.
PubMed Abstract available

NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
PLoS One. 2024;19:e0306044.
PubMed Abstract available

DEBELLUT F, Friedrich A, Baral R, Pecenka C, et al
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature.
PLoS One. 2024;19:e0305692.
PubMed Abstract available

WERDIN S, Neufeind J
The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
PLoS One. 2024;19:e0306003.
PubMed Abstract available

BOTELHO RO, Coelho CCF, Andrade EF, Castelo PM, et al
Fear of the COVID-19 vaccine in a public healthcare system and university setting.
PLoS One. 2024;19:e0304000.
PubMed Abstract available

CARLOCK MA, Allen JD, Hanley HB, Ross TM, et al
Longitudinal assessment of human antibody binding to hemagglutinin elicited by split-inactivated influenza vaccination over six consecutive seasons.
PLoS One. 2024;19:e0301157.
PubMed Abstract available

AKRONG GB, Hiadzi RA, Donkor AB, Anafo DK, et al
COVID-19 vaccine acceptance and hesitancy in Ghana: A systematic review.
PLoS One. 2024;19:e0305993.
PubMed Abstract available

YU H, Bonett S, Oyiborhoro U, Aryal S, et al
Psychosocial correlates of parents' willingness to vaccinate their children against COVID-19.
PLoS One. 2024;19:e0305877.
PubMed Abstract available

FERRIS BF, Balasubramanian S, Rajamanickam A, Munisankar S, et al
Relative contribution of biomedical, demographic, and socioeconomic factors to COVID-19 vaccine receipt in rural India.
PLoS One. 2024;19:e0305819.
PubMed Abstract available

YAZDANI Y, Pai P, Sayfi S, Mohammadi A, et al
Predictors of COVID-19 vaccine acceptability among refugees and other migrant populations: A systematic scoping review.
PLoS One. 2024;19:e0292143.
PubMed Abstract available

SMITH DG, Smith CD, DeLeon JA, Sandoz JL, et al
Factors influencing COVID-19 vaccine uptake among Latinos: A cross-sectional study.
PLoS One. 2024;19:e0302332.
PubMed Abstract available

BHATTACHARJEE A, Hosen MR, Lamisa AB, Ahammad I, et al
An integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine.
PLoS One. 2024;19:e0292413.
PubMed Abstract available

RAJI T, Fallah MP, Dereje N, Kakooza F, et al
Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.
PLoS One. 2024;19:e0306309.
PubMed Abstract available

MAHARLOUEI N, Hosseinpour P, Erfani A, Shahriarirad R, et al
Correction: Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022.
PLoS One. 2024;19:e0307336.
PubMed Abstract available

TAREKE AA, Tewabe Ayelign A, Yewodiaw TK, Shiferaw EW, et al
Retention rate of vaccination card and its associated factors among vaccinated children aged 12 horizontal line 23 months in Ethiopia: Multilevel logistic regression analysis.
PLoS One. 2024;19:e0306421.
PubMed Abstract available

AL-RASHDAN RA, Ta'an W, Mukattash T, Williams B, et al
Maternal skepticism regarding children's vaccination in Jordan: Investigating the knowledge, attitude, and adherence.
PLoS One. 2024;19:e0305209.
PubMed Abstract available

MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
PLoS One. 2024;19:e0305413.
PubMed Abstract available

OLANI KUTA A, Dida N
Covid-19 vaccine hesitancy and its predictors among diabetic patients on follow-up at public hospitals in Nekemte Town, Western Ethiopia.
PLoS One. 2024;19:e0305200.
PubMed Abstract available

ZEGEYE AF, Mekonen EG, Tekeba B, Alemu TG, et al
Spatial distribution and determinants of measles vaccination dropout among under-five children in Ethiopia: A spatial and multilevel analysis of 2019 Ethiopian demographic and health survey.
PLoS One. 2024;19:e0305393.
PubMed Abstract available

SALAZAR JC, Vargas-Cely F, Garcia-Luna JA, Ramirez LG, et al
Treponema pallidum genetic diversity and its implications for targeted vaccine development: A cross-sectional study of early syphilis cases in Southwestern Colombia.
PLoS One. 2024;19:e0307600.
PubMed Abstract available

ZEHRA A, Jamil S, Farman M, Nisar KS, et al
Modeling and analysis of Hepatitis B dynamics with vaccination and treatment with novel fractional derivative.
PLoS One. 2024;19:e0307388.
PubMed Abstract available

MANSOUR AA, Hussein SM, Felemban SG, Mahamid AW, et al
Correction: Acceptance and hesitancy of parents to vaccinate children against coronavirus disease 2019 in Saudi Arabia.
PLoS One. 2024;19:e0307674.
PubMed Abstract available

QUEE FA, Hogema BM, Molier M, Slot E, et al
The Elecsys(R) Anti-SARS-CoV-2 and Elecsys(R) Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
PLoS One. 2024;19:e0305613.
PubMed Abstract available

HOY C, Wood T, Moscoe E
Correction: Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
PLoS One. 2024;19:e0307570.
PubMed Abstract available

Retraction: Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs.
PLoS One. 2024;19:e0307483.
PubMed

NOURANI L, Mehrizi AA, Zakeri S, Djadid ND, et al
Correction: Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates.
PLoS One. 2024;19:e0307447.
PubMed Abstract available

LEE J, Lee CW, Suarez DL, Lee SA, et al
Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens.
PLoS One. 2024;19:e0307100.
PubMed Abstract available

VAN DEN BOSSCHE J, De Laere M, Deschepper K, Germonpre P, et al
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study.
PLoS One. 2024;19:e0307204.
PubMed Abstract available

BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
PLoS One. 2024;19:e0307880.
PubMed Abstract available

BINDER RA, Matta AM, Forconi CS, Oduor CI, et al
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools.
PLoS One. 2024;19:e0307568.
PubMed Abstract available

TREGNAGO D, Avancini A, Belluomini L, Trestini I, et al
Correction: Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
PLoS One. 2024;19:e0307924.
PubMed Abstract available

RASHITI-BYTYCI A, White Johansson E, Kacaniku-Gunga P, Danis K, et al
Estimation of COVID-19 vaccine effectiveness against infections and severe outcomes using routine surveillance data in Kosovo, July-September 2021.
PLoS One. 2024;19:e0305629.
PubMed Abstract available

RIEDMILLER I, Fougeroux C, Jensen RW, Kana IH, et al
Mosaic and cocktail capsid-virus-like particle vaccines for induction of antibodies against the EPCR-binding CIDRalpha1 domain of PfEMP1.
PLoS One. 2024;19:e0302243.
PubMed Abstract available

MANTINA NM, Ngaybe MGB, Zeiders KH, Osman KM, et al
Latinx youth's and parents' covid-19 beliefs, vaccine hesitancy and vaccination rates: Longitudinal associations in a community sample.
PLoS One. 2024;19:e0307479.
PubMed Abstract available

ALI L, Rauf S, Khan A, Rasool S, et al
In silico design of multi-epitope vaccines against the hantaviruses by integrated structural vaccinology and molecular modeling approaches.
PLoS One. 2024;19:e0305417.
PubMed Abstract available

GONZALEZ-BLOCK MA, Gutierrez-Calderon E, Pelcastre-Villafuerte BE, Arroyo-Laguna J, et al
Correction: Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates.
PLoS One. 2024;19:e0308524.
PubMed Abstract available

OGOLLA KO, Anyona DN, Chemuliti JK, Kimani WW, et al
Effectiveness of a community-centered Newcastle disease vaccine delivery model under paid and free vaccination frameworks in southeastern Kenya.
PLoS One. 2024;19:e0308088.
PubMed Abstract available

FUKUI S
Unravelling habituation for COVID-19-related information: A panel data study in Japan.
PLoS One. 2024;19:e0306456.
PubMed Abstract available

THOMPSON O, Cristea M, Tamariz M
COVID-19 vaccination attitudes and uptake: A sociocultural perspective focusing on parents and peers.
PLoS One. 2024;19:e0300771.
PubMed Abstract available

MAKI KO, Karlsson LC, Kaakinen JK, Schmid P, et al
COVID-19 and influenza vaccine-hesitancy subgroups.
PLoS One. 2024;19:e0308159.
PubMed Abstract available

SERWANGA J, Oluka GK, Baine C, Ankunda V, et al
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
PLoS One. 2024;19:e0303113.
PubMed Abstract available

FOPPIANI A, Montanari C, Zanelli S, Lombardo MDM, et al
Long-COVID symptom monitoring: Insights from a two-year telemedicine study.
PLoS One. 2024;19:e0307834.
PubMed Abstract available

SANDBORN H, Delamater P, Brewer NT, Gilkey MB, et al
The geography of COVID-19 vaccine completion by age in North Carolina, U.S.
PLoS One. 2024;19:e0304812.
PubMed Abstract available

RUDOLPH L, Koubi V, Freihardt J
COVID-19 vaccination uptake in remote areas-Evidence from a panel survey in Bangladesh.
PLoS One. 2024;19:e0305659.
PubMed Abstract available

NAKIBUUKA V, Muddu M, Kraehenbuhl JP, Birungi C, et al
Uptake of human papilloma virus vaccination among adolescent girls living with HIV in Uganda: A mixed methods study.
PLoS One. 2024;19:e0300155.
PubMed Abstract available

MORENO ECHEVARRIA F, Caputo M, Camp D, Reddy S, et al
Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago.
PLoS One. 2024;19:e0302338.
PubMed Abstract available

ARSHAD NF, Nordin FJ, Foong LC, In LLA, et al
Engineering receptor-binding domain and heptad repeat domains towards the development of multi-epitopes oral vaccines against SARS-CoV-2 variants.
PLoS One. 2024;19:e0306111.
PubMed Abstract available

SKIRROW H, Lewis C, Haque H, Choundary-Salter L, et al
The impact of the COVID-19 pandemic on UK parents' attitudes towards routine childhood vaccines: A mixed-methods study.
PLoS One. 2024;19:e0306484.
PubMed Abstract available

EZEZIKA O, Adedugbe T, Jonas I, Mengistu M, et al
Resilience throughout COVID-19: Unmasking the realities of COVID-19 and vaccination facilitators, barriers, and attitudes among Black Canadians.
PLoS One. 2024;19:e0304904.
PubMed Abstract available

JIANG H, Zhang C, Meng X, Chi S, et al
COVID-19, vaccination and migraine: Causal association or epiphenomenon?
PLoS One. 2024;19:e0308151.
PubMed Abstract available

WRIGHT J, Crowcroft N, McLachlan E, Perez-Iratxeta C, et al
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study.
PLoS One. 2024;19:e0309154.
PubMed Abstract available

GIDADO S, Musa M, Ba'aba AI, Okeke LA, et al
COVID-19 vaccination intention among internally displaced persons in complex humanitarian emergency context, Northeast Nigeria.
PLoS One. 2024;19:e0308139.
PubMed Abstract available

GAULD NJ, Knapton C, Sinclair O, Grant CC, et al
Promotion and COVID-19 lockdown increase uptake of funded maternal pertussis vaccination in pharmacy: A mixed methods study.
PLoS One. 2024;19:e0307971.
PubMed Abstract available

KISA S, Kisa A
Religious beliefs and practices toward HPV vaccine acceptance in Islamic countries: A scoping review.
PLoS One. 2024;19:e0309597.
PubMed Abstract available

LEON-ROJAS JE, Arias-Erazo F, Jimenez-Arias P, Recalde-Navarrete R, et al
COVID-19 IgG seropositivity and its determinants in occupational groups of varying infection risks in two Andean cities of Ecuador before mass vaccination.
PLoS One. 2024;19:e0309466.
PubMed Abstract available

BERROU I, Hobbs L, Jones S, Hughes S, et al
Lessons learnt from the implementation of the Covid-19 vaccination programme in the Southwest of England.
PLoS One. 2024;19:e0309230.
PubMed Abstract available

BARQAWI HJ, Samara KA, Kannas SM, Habbal O, et al
Vaccine practices, literacy, and hesitancy among parents in the United Arab Emirates.
PLoS One. 2024;19:e0307020.
PubMed Abstract available

FRITSCHI N, Gureva T, Eliseev P, Jackson C, et al
Diagnosis of tuberculosis infection in children with a novel skin test and the traditional tuberculin skin test: An observational study.
PLoS One. 2024;19:e0293272.
PubMed Abstract available

MCKEE S, Halsall T, Sheikhan NY, Knight R, et al
"Pictures helped me understand it in a way words couldn't": Youth reflections participating in a youth-led photovoice study.
PLoS One. 2024;19:e0308165.
PubMed Abstract available

SHI H, Zhu Y, Shang K, Tian T, et al
Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approaches.
PLoS One. 2024;19:e0307877.
PubMed Abstract available

KATZ MA, Rojas Castro MY, Chakhunashvili G, Chitadze N, et al
Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March-December 2021.
PLoS One. 2024;19:e0307805.
PubMed Abstract available

NGUYEN K, Relja B, Epperson M, Park SH, et al
Salivary immune responses after COVID-19 vaccination.
PLoS One. 2024;19:e0307936.
PubMed Abstract available

SHEN J, Ji C, Luo X, Hu Y, et al
Economic evaluation on meningococcal vaccination strategies among children under nine years of age in Zhejiang province, China.
PLoS One. 2024;19:e0310274.
PubMed Abstract available

SHRESTHA M, Sherer PP, Paek SC, Prasert K, et al
Influenza vaccine hesitancy among healthcare workers in a Northeastern province in Thailand: Findings of a cross-sectional survey.
PLoS One. 2024;19:e0310761.
PubMed Abstract available

GHOSH S, Banerjee M, Chattopadhyay AK
Effect of vaccine dose intervals: Considering immunity levels, vaccine efficacy, and strain variants for disease control strategy.
PLoS One. 2024;19:e0310152.
PubMed Abstract available

PARVIN R, Habib Ullah Masum M, Ferdous J, Mahdeen AA, et al
Designing of a chimeric multiepitope vaccine against bancroftian lymphatic filariasis through immunoinformatics approaches.
PLoS One. 2024;19:e0310398.
PubMed Abstract available

MAHASING C, Suphanchaimat R, Teekasap P, Nittayasoot N, et al
Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023.
PLoS One. 2024;19:e0310427.
PubMed Abstract available

MOGHNIEH R, Haddad W, Jbeily N, El-Hassan S, et al
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization.
PLoS One. 2024;19:e0306457.
PubMed Abstract available

HASHEMPOUR A, Khodadad N, Bemani P, Ghasemi Y, et al
Design of multivalent-epitope vaccine models directed toward the world's population against HIV-Gag polyprotein: Reverse vaccinology and immunoinformatics.
PLoS One. 2024;19:e0306559.
PubMed Abstract available

BUNDUR A, Riaz R, Elibol FKE, Demir T, et al
Effects of spray-dried plasma on performance, carcass parameters, tibia quality and Newcastle disease vaccine efficacy in broiler chicken fed corn-soy diets with two varying levels of digestible amino acids and AMEn density.
PLoS One. 2024;19:e0309263.
PubMed Abstract available

BANICO EC, Sira EMJS, Fajardo LE, Dulay ANG, et al
Advancing one health vaccination: In silico design and evaluation of a multi-epitope subunit vaccine against Nipah virus for cross-species immunization using immunoinformatics and molecular modeling.
PLoS One. 2024;19:e0310703.
PubMed Abstract available

KIAKUVUE YN, Mall S, Govender N, Gottberg AV, et al
Demographic and pathogen characteristics of incident bacterial meningitis in infants in South Africa: A cohort study.
PLoS One. 2024;19:e0310528.
PubMed Abstract available

EZEZIKA O, Kotsaftis TS, Marson A
Upstream factors impacting COVID-19 vaccination rates across Africa: A systematic review protocol.
PLoS One. 2024;19:e0310884.
PubMed Abstract available

LEE MF, Chen YH, Song PP, Lin TM, et al
Correction: Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy.
PLoS One. 2024;19:e0311200.
PubMed Abstract available

JEON HE, Lee S, Lee J, Roh G, et al
SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation.
PLoS One. 2024;19:e0311726.
PubMed Abstract available

WORKU BT, Wordofa EA, Senbeto G, Zinab B, et al
Age-appropriate vaccination and associated factors among children aged 12-35 months in Ethiopia: A multi-level analysis.
PLoS One. 2024;19:e0305801.
PubMed Abstract available

MCNEILL-JOHNSON A, Hudson Z, Moore B, Okocha D, et al
Pandemic perspectives from detained youth during COVID-19: Bridging the knowledge gap for future safeguards.
PLoS One. 2024;19:e0309179.
PubMed Abstract available

BOLIJN R, Spijkerman AMW, Galenkamp H, Blokstra A, et al
Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study.
PLoS One. 2024;19:e0311196.
PubMed Abstract available

MWIINDE AM, Kaonga P, Jacobs C, Zulu JM, et al
Determinants of COVID-19 vaccine acceptance and hesitancy among adolescents and youths aged 10-35 years in sub-Saharan African countries: A systematic review and meta-analysis.
PLoS One. 2024;19:e0310827.
PubMed Abstract available

FLOOD T, McLaughlin DM, Wilson DI, Hughes CM, et al
An exploration of teacher and school-based nurse perceptions of current HPV education offered to students 15-16 years old in post-primary schools in Northern Ireland, UK.
PLoS One. 2024;19:e0311651.
PubMed Abstract available

BUI DP, Bajema KL, Huang Y, Yan L, et al
Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023.
PLoS One. 2024;19:e0307235.
PubMed Abstract available

HARTANTI MD, Panjaitan NSD, Sunarno S, Ningrum N, et al
Seroprevalence of Bordetella pertussis infection in children 1-14 years old: Indonesia basic health research (Riskesdas) 2013 and 2018 data.
PLoS One. 2024;19:e0311362.
PubMed Abstract available

BILGIN GM, Munira SL, Lokuge K, Glass K, et al
Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals: Case studies in the Indo-Pacific.
PLoS One. 2024;19:e0294091.
PubMed Abstract available

MULLER DL, Stuckey H, Flores ES, Wang L, et al
Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study.
PLoS One. 2024;19:e0312168.
PubMed Abstract available

ALRABADI N, Obeidat H, Haddad R, Alyassin N, et al
The value of using COVID-19 antibody tests as a potential approach to prioritize vaccination delivery.
PLoS One. 2024;19:e0311881.
PubMed Abstract available

NAQVI AA, Islam MA, Jahangir A, Rizvi M, et al
Cross-cultural adaptation and validation of an Urdu version of the Vaccine Attitudes Examination (VAX-U) scale.
PLoS One. 2024;19:e0312459.
PubMed Abstract available

MAAMOR NH, Muhamad NA, Mohd Dali NS, Leman FN, et al
Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis.
PLoS One. 2024;19:e0302379.
PubMed Abstract available

MAHDEEN AA, Hossain I, Masum MHU, Islam S, et al
Designing novel multiepitope mRNA vaccine targeting Hendra virus (HeV): An integrative approach utilizing immunoinformatics, reverse vaccinology, and molecular dynamics simulation.
PLoS One. 2024;19:e0312239.
PubMed Abstract available

LEE AA, Skyles TJ, Jensen JL, Ord B, et al
Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah.
PLoS One. 2024;19:e0312549.
PubMed Abstract available

LI S, Li W
Dynamical behaviors of a stochastic SIVS epidemic model with the Ornstein-Uhlenbeck process and vaccination of newborns.
PLoS One. 2024;19:e0310175.
PubMed Abstract available

KIM Y, Lim MK
The potential role of perceived neighborhood social cohesion on COVID-19 vaccination uptake among individuals aged 50 and older: Results from the Korean Community Health Survey.
PLoS One. 2024;19:e0312309.
PubMed Abstract available

ELSEY JWB, Manheim D, Marsh A, Schmit V, et al
Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel.
PLoS One. 2024;19:e0307808.
PubMed Abstract available

NEBANGWA DN, Shey RA, Shadrack DM, Shintouo CM, et al
Predictive immunoinformatics reveal promising safety and anti-onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials.
PLoS One. 2024;19:e0312315.
PubMed Abstract available

YOUSSEF E, Calvert A, Greening V, Pearce D, et al
Understanding the barriers and enablers to participation in vaccine trials in a pregnant population from diverse ethnic background in an inner-city UK hospital.
PLoS One. 2024;19:e0312799.
PubMed Abstract available

ZANIB SA, Zubair T, Ramzan S, Riaz MB, et al
A conformable fractional finite difference method for modified mathematical modeling of SAR-CoV-2 (COVID-19) disease.
PLoS One. 2024;19:e0307707.
PubMed Abstract available

PELZER PT, Holleman M, Helinski MEH, Weinberg AL, et al
The TB vaccine clinical trial centre directory: An inventory of clinical trial centres in Sub-Saharan Africa.
PLoS One. 2024;19:e0292981.
PubMed Abstract available

ZHU Y, Shi J, Wang Q, Zhu Y, et al
Novel dual-pathogen multi-epitope mRNA vaccine development for Brucella melitensis and Mycobacterium tuberculosis in silico approach.
PLoS One. 2024;19:e0309560.
PubMed Abstract available

AYAZ H, Celik MH, Koytak HZ, Yanik IE, et al
Exploring vaccine hesitancy in digital public discourse: From tribal polarization to socio-economic disparities.
PLoS One. 2024;19:e0308122.
PubMed Abstract available

NANTEZA MB, Nanyonjo G, Kyakuwa N, Nakanjako F, et al
COVID-19 vaccine uptake and associated factors among individuals living in a peri-urban area in Uganda: A cross-sectional study.
PLoS One. 2024;19:e0312377.
PubMed Abstract available

OYEDEJI O, Kintziger KW, Springer CM, Ehrlich S, et al
Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model.
PLoS One. 2024;19:e0312700.
PubMed Abstract available

KUDDUS MA, Mohiuddin M, Paul AK, Rahman A, et al
Insights from qualitative and bifurcation analysis of COVID-19 vaccination model in Bangladesh.
PLoS One. 2024;19:e0312780.
PubMed Abstract available

KLEGERMAN ME, Peng T, Seferovich I, Rahbar MH, et al
Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies.
PLoS One. 2024;19:e0311777.
PubMed Abstract available

SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
Correction: Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
PLoS One. 2024;19:e0314048.
PubMed Abstract available

LI Y, Kong D, Ding Y, Wang J, et al
The potential impact of COVID-19 vaccination on patients with immune thrombocytopenic purpura: A protocol for systematic review and meta-analysis.
PLoS One. 2024;19:e0308546.
PubMed Abstract available

HAWLADER MDH, Eva FN, Khan MAS, Islam T, et al
Acceptance of Human Papillomavirus (HPV) vaccine among the parents of eligible daughters (9-15 years) in Bangladesh: A nationwide study using Health Belief Model.
PLoS One. 2024;19:e0310779.
PubMed Abstract available

EZEZIKA O, Kotsaftis TS, Amponsah-Dacosta E, Demi S, et al
A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.
PLoS One. 2024;19:e0311800.
PubMed Abstract available

CHEWASKULYONG B, Satjaritanun P, Ketpueak T, Suksombooncharoen T, et al
Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.
PLoS One. 2024;19:e0310781.
PubMed Abstract available

GUPTA MD, Kunal S, M P G, Goyal D, et al
Correction: Impact of COVID-19 vaccination on mortality after acute myocardial infarction.
PLoS One. 2024;19:e0314647.
PubMed Abstract available

VASUDEVAN L, Porter RM, Campos I, Turner EL, et al
An ADaptivE PrenaTal (ADEPT) intervention to increase childhood vaccinations: Protocol for a cluster randomized trial and nested mixed methods evaluation.
PLoS One. 2024;19:e0313742.
PubMed Abstract available

DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
PLoS One. 2024;19:e0310591.
PubMed Abstract available

HAMDAN O, Amarin JZ, Potter M, Haddadin Z, et al
Seasonal influenza vaccination: Attitudes and practices of healthcare providers in Jordan.
PLoS One. 2024;19:e0314224.
PubMed Abstract available

SHURO L, Lawrence E, Knight L, Schneider H, et al
Enhancing childhood immunization coverage in Mozambique and Malawi: Study protocol of a mixed methods evaluation of the 'Let's talk about vaccines' multisite community-based participatory project.
PLoS One. 2024;19:e0311052.
PubMed Abstract available

STREETER AJ, Rodgers LR, Masoli J, Lin NX, et al
Correction: Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink.
PLoS One. 2024;19:e0314373.
PubMed Abstract available

ANNI NS, Rehman N, Nyambi A, Musiwa A, et al
Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review.
PLoS One. 2024;19:e0313887.
PubMed Abstract available

JUNGKUNZ S
Asymmetric polarization by vaccination status identification during the COVID-19 pandemic.
PLoS One. 2024;19:e0311962.
PubMed Abstract available

MARRA F, Yip M, Cragg JJ, Vadlamudi NK, et al
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations.
PLoS One. 2024;19:e0313889.
PubMed Abstract available

LAMICHHANE R, Adhikari P, Pathak BD, Rai A, et al
Knowledge, attitude, and practice towards Hepatitis B and vaccination status of pre-clinical medical students at Sylhet Women's Medical College, Bangladesh.
PLoS One. 2024;19:e0310443.
PubMed Abstract available

SITA L, Caserotti M, Zamparini M, Lotto L, et al
Impact of COVID-19 vaccination on preventive behavior: The importance of confounder adjustment in observational studies.
PLoS One. 2024;19:e0313117.
PubMed Abstract available

RODRIGUES DA SILVA TP, Moreira CM, Souza JFA, Fernandes EG, et al
Risk classification for the transmission of vaccine-preventable diseases in the state of Minas Gerais, Brazil: 2018 to 2022.
PLoS One. 2024;19:e0311932.
PubMed Abstract available

HANDAYANI S, Rias YA, Kurniasari MD, Agustin R, et al
Correction: Relationship of spirituality, health engagement, health belief and attitudes toward acceptance and willingness to pay for a COVID-19 vaccine.
PLoS One. 2024;19:e0315519.
PubMed Abstract available

SANDERS C, Burnett K, Ray L, Ulanova M, et al
An exploration of the role of trust and rapport in enhancing vaccine uptake among Anishinaabe in rural northern Ontario.
PLoS One. 2024;19:e0308876.
PubMed Abstract available

MOSANYA AU, Ezekwelu A, Ugochukwu EJ, Ukoha-Kalu BO, et al
Factors associated with post-pandemic acceptance of COVID-19 vaccines among students in three Nigerian universities.
PLoS One. 2024;19:e0312271.
PubMed Abstract available

SIBANDA M, Burnett RJ, Godman B, Meyer JC, et al
Vaccine uptake, associated factors and reasons for vaccination status among the South African elderly; findings and next steps.
PLoS One. 2024;19:e0314098.
PubMed Abstract available

SARKER A, Rahman MM, Khatun C, Barai C, et al
In Silico design of a multi-epitope vaccine for Human Parechovirus: Integrating immunoinformatics and computational techniques.
PLoS One. 2024;19:e0302120.
PubMed Abstract available

HURST JR, Naghibosadat M, Budowski P, Liu J, et al
Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.
PLoS One. 2024;19:e0314061.
PubMed Abstract available

SANTOSH AK, Kumar D, Kaur C, Gupta P, et al
Evaluation of the immune status of dogs vaccinated against rabies by an enzyme-linked immunosorbent assay using crude preparations of insect cells infected with a recombinant baculovirus encoding the rabies virus glycoprotein gene.
PLoS One. 2024;19:e0314516.
PubMed Abstract available

EHSASATVATAN M, Baghban Kohnehrouz B
Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types.
PLoS One. 2024;19:e0311351.
PubMed Abstract available

GUERRERIO AL, Mateja A, MacCarrick G, Fintzi J, et al
Cardiovascular complications in vascular connective tissue disorders after COVID-19 infection and vaccination.
PLoS One. 2024;19:e0315499.
PubMed Abstract available

Correction: Vaccination against misinformation: The inoculation technique reduces the continued influence effect.
PLoS One. 2024;19:e0316311.
PubMed Abstract available

EDOSSA ZK, Erchafo Lubago B, Baye MF, Alemu RK, et al
Vaccination card loss and associated factors in Ethiopia: A multilevel analysis using Ethiopia Mini Demographic and Health Survey 2019 data.
PLoS One. 2024;19:e0311925.
PubMed Abstract available

BEISSEGULOVA G, Ramazanova B, Mustafina K, Begadilova T, et al
Prevalence of nasopharyngeal Streptococcus Pneumoniae carriage in infants: A systematic review and meta-analysis of cohort studies and randomized controlled trials.
PLoS One. 2024;19:e0315461.
PubMed Abstract available

ZHENG J, Li B, Jia L, Zhang J, et al
Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.
PLoS One. 2024;19:e0311069.
PubMed Abstract available

D'SOUZA GC, Yingst JM, Krebs NM, Bordner C, et al
Using the diffusion of innovations theory to understand factors associated with COVID-19 vaccination among tobacco users.
PLoS One. 2024;19:e0309780.
PubMed Abstract available

NAULLY PG, Tan MI, Nugrahapraja H, Artarini AA, et al
Design of multi-epitope-based therapeutic vaccine candidates from HBc and HBx proteins of hepatitis B virus using reverse vaccinology and immunoinformatics approaches.
PLoS One. 2024;19:e0313269.
PubMed Abstract available

SABATER-GARRIZ A, Ceron JJ, Montoya P, Riquelme I, et al
Potential use of salivary TNF-alpha as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders.
PLoS One. 2024;19:e0308386.
PubMed Abstract available

TARIGAN S, Sekarmila G, Apas, Sumarningsih, et al
Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.
PLoS One. 2024;19:e0306153.
PubMed Abstract available

ZHANG Y, Guo X, Su Y
Spatiotemporal dynamic and regional differences of public attention to vaccination: An empirical study in China.
PLoS One. 2024;19:e0312488.
PubMed Abstract available

BROECKL CV, Hiereth S, Straubinger RK
A comparative study evaluating three line immunoassays available for serodiagnosis of equine Lyme borreliosis: Detection of Borrelia burgdorferi sensu lato-specific antibodies in serum samples of vaccinated and non-vaccinated horses.
PLoS One. 2024;19:e0316170.
PubMed Abstract available

HOLLISTER J, Porter C, Sprissler R, Beitel SC, et al
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance.
PLoS One. 2024;19:e0306953.
PubMed Abstract available

CHO S, Hisamitsu S, Jin H, Toyoda M, et al
Analyzing information sharing behaviors during stance formation on COVID-19 vaccination among Japanese Twitter users.
PLoS One. 2024;19:e0299935.
PubMed Abstract available

SAMI MRS, Rani NA, Elahi MME, Hossain MS, et al
An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis.
PLoS One. 2024;19:e0315105.
PubMed Abstract available

CAO Q, Hou Y, Wang C, Yin J, et al
Effect of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: A systematic review and meta-analysis.
PLoS One. 2024;19:e0312128.
PubMed Abstract available

HASSAN MZ, Basher AK, Rahman MZ, Bhuiyan TR, et al
Study protocol for COVID-19 breakthrough infections and vaccine-induced immune response among a cohort of healthcare workers, Bangladesh.
PLoS One. 2024;19:e0316121.
PubMed Abstract available

AGIMAS MC, Asmamaw M, Hailu MK, Kidie T, et al
Geospatial mapping to assess the distribution and determinants of zero dose vaccination status hot spots among children in Ethiopia using EDHS 2019: Spatial and geographical weighted regression.
PLoS One. 2024;19:e0312610.
PubMed Abstract available

BHENGU P, Ndwandwe D, Cooper S, Katoto PDMC, et al
Behavioural and social drivers of human papillomavirus vaccination in eThekwini District of KwaZulu-Natal Province, South Africa.
PLoS One. 2024;19:e0311509.
PubMed Abstract available

DOMNICH A, Trombetta CS, Fallani E, Salvatore M, et al
Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis.
PLoS One. 2024;19:e0310677.
PubMed Abstract available

NORANATE N, Sripanomphong J, Mphande-Nyasulu FA, Chaorattanakawee S, et al
Plasmodium falciparum surf4.1 in clinical isolates: From genetic variation and variant diversity to in silico design immunopeptides for vaccine development.
PLoS One. 2024;19:e0312091.
PubMed Abstract available

BELAYACHI J, Obtel M, Mhayi A, Razine R, et al
Correction: Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
PLoS One. 2024;19:e0316865.
PubMed Abstract available

ABDULLAH M, Ahmad T, Khan A, Kazmi T, et al
Correction: Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan.
PLoS One. 2024;19:e0316862.
PubMed Abstract available

SATO Y, Kawachi I, Saijo Y, Yoshioka E, et al
Correlates of COVID-19 conspiracy theory beliefs in Japan: A cross-sectional study of 28,175 residents.
PLoS One. 2024;19:e0310673.
PubMed Abstract available

LAARMAN C, Hahne SJ, de Melker HE, Knol MJ, et al
SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.
PLoS One. 2024;19:e0311229.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.